HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Real-world effectiveness and safety of risankizumab in patients with plaque psoriasis in whom guselkumab failed recently: A multicenter retrospective study of switching within the interleukin-23 inhibitor class.

AuthorsAhmed Bagit, Khalad Maliyar, Jorge R Georgakopoulos, Brian Rankin, Alexander Rimke, Asfandyar Mufti, Heather Le, Ronald Vender, Vimal H Prajapati, Jensen Yeung
JournalJAAD international (JAAD Int) Vol. 12 Pg. 136-138 (Sep 2023) ISSN: 2666-3287 [Electronic] United States
PMID37409313 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: